Health Care·Health Care Equipment·$32.0B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.73 | N/A | +4.89% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.73 | N/A | +4.89% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed cautious optimism about future demand for their products. They acknowledged some supply chain challenges but are focused on innovation.
Management highlighted ongoing demand for sleep apnea products.
They noted challenges in the global supply chain but remain focused on innovation.
The team emphasized their commitment to long-term growth despite short-term hurdles.
ResMed's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock's slight decline suggests that investors may have been looking for more comprehensive revenue details or guidance. The lack of revenue numbers and guidance could lead to uncertainty among investors moving forward.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
GE AEROSPACE
Jan 20, 2017